Private equity’s interest in healthcare has exploded in recent years. But a new report shows firms are increasingly challenged by companies’ high prices.
High prices test private equity’s ability to close healthcare deals
Private equity’s interest in healthcare has exploded in recent years. But a new report shows firms are increasingly challenged by companies’ high prices.